NCT06079073

Brief Summary

The overall aim of this study is to estimate the effect of orofacial myofunctional therapy (OMT) plus auto-monitoring compared to auto-monitoring alone. Moreover, the investigators aim to identify anatomical and behavioural predictors of OMT adherence

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

August 29, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 12, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 29, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2025

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

1.6 years

First QC Date

August 23, 2023

Last Update Submit

March 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Apnea hypopnea index reduction

    Measured by self-applied somnography. The index represents number of apneas or hypopneas per hour from 0/h. Higher values represents more severe disease.

    3 months

Secondary Outcomes (15)

  • Change in the Epworth Sleepines scale

    3 months

  • Orofacial myofunctional therapy adherence

    3 months

  • Change in desaturation severity parameter measured by medical device

    3 months

  • Change in desaturation duration measured by medical device

    3 months

  • Change in objective sleep quality

    3 months

  • +10 more secondary outcomes

Study Arms (2)

Application plus treatment module

EXPERIMENTAL

The following exercises are pre-recorded and presented in the treatment module: Tongue 1. Tongue brushing 2. Tongue sliding 3. Tongue suction 4. Tongue down Soft palate 1\. Elevate soft palate and uvula 2. Balloon blow Facial 1. Put your finger in the oral cavity against your cheek. Pull against your finger with the cheek muscles. 2. Air pump Exercise adherence is registered in a study application

Behavioral: Orofacial myofunctional therapy with autofeedback

Application awaiting access to treatment module

NO INTERVENTION

Participants receiving a code not unlocking the treatment module will have full access to all other parts of the mobile app. After 90 days, during the outcome evaluation, all participants will receive a new code unlocking the treatment module in order to keep outcome evaluators blinded.

Interventions

Participants opening a code unlocking the OMTa treatment module of the application will be given a direct communication link to the PhD students, Diana Hansen (Norway) and Andres Koster (Estonia) and two research co-ordinators. Dr. Hansen and Andres Köster has obtained an Academy of Orofacial Myofunctional Therapy (AOMT) certification diploma. One physical start up session will be scheduled at Ahus and at North Estonia Medical Center. This 60 minute session will be used to instruct participants in OMT exercises and use of the app. All participants will receive a disposable toothbrush and standardized balloons. After that, biweekly video sessions (time 20-30 min) will be scheduled.

Application plus treatment module

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsCategory "non-binary" possible
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients referred to Ahus or the Fertilitas clinic
  • A diagnosis of obstructive sleep apnea according to the current International Classsification of Sleep Disorders (ICSD) version 3 criteria {Berry, 2020, The AASM Manual for the Scoring of Sleep and Associated Events: Rules', Terminology and Technical Specifications', Version 2.6.;, 2014, International classification of sleep disorders', 3rd ed.}, with a respiratory event index (REI) \<30.
  • Not previously or currently treated with PAP or MAD
  • Signed informed, written consent.
  • Owning a mobile phone with software compatible for the study application Age ≥18 year.
  • Body mass index \<30
  • Ability to breathe through the nose
  • Ability to read and willingness to follow the protocol as described in the written consent form
  • Teeth 5-to 5 should be present or fixed by prosthesis or implants.
  • No botulinium toxin in facial muscles last three months

You may not qualify if:

  • Failure to fill in at least 70% of days in the electronic sleep diary provided in the mobile app for two weeks.
  • Tongue-tie as described below. Participants with mouth opening of \<50% with the tip of the tongue at the incisive papilla compared to total mouth opening will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fertilitas clinic

Tallinn, 10114, Estonia

Location

Akershus University Hospital

Lørenskog, Akershus, 1478, Norway

Location

Related Publications (1)

  • Koster A, Hoang AD, Dashuk A, Vaher H, Sikk K, Jagomagi T. Effects of Web-Based Orofacial Myofunctional Therapy on Hyoid Bone Position in Adults with Mild to Moderate Obstructive Sleep Apnea: Evidence from an Estonian Substudy of a Randomized Controlled Trial. J Clin Med. 2025 Dec 29;15(1):257. doi: 10.3390/jcm15010257.

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Harald Hrubos-Strøm, PhD

    University Hospital, Akershus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Randomization is conducted at the end of the baseline assessment. Participants in the intervention group is handled by an OMT therapist until outcome assessment by the same postdoc student that did the baseline examination. The postdoc student has not been in contact with any participant during the intervention period.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Block randomization to ensure 40% female participants. Intervention: Access to treatment module in application plus access to OMT therapist. Control: Access to application without treatment module. No scheduled appointments with OMT therapist.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, senior consultant and head of research group, principal investigator

Study Record Dates

First Submitted

August 23, 2023

First Posted

October 12, 2023

Study Start

August 29, 2023

Primary Completion

March 29, 2025

Study Completion

March 29, 2025

Last Updated

April 1, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Not allowed by Regional Ethical Committee

Locations